RSS

asthma

Digital Innovations Hubs are to be created in the UK to help connect data and fast-track treatments for a range of important diseases like cancer, heart disease and asthma. more

News

As a new era of digital drug delivery is making headway, Dr Steven Wick, vice president, Product Development & Commercialisation, 3M Drug Delivery Systems, gives us his thoughts on this digital future. more

Opinion

Diagnostics company, Owlstone Medical, has signed a service agreement with global biopharmaceutical company, AstraZeneca, to explore how breath can be used to identify novel biomarkers for personalised medicine applications. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

The European Medicines Agency (EMA) has accepted for review an application for an add-on maintenance treatment in certain adults and adolescents (12 years and older) with inadequately controlled moderate-to-severe asthma, Dupixent (dupilumab). more

News

A patient and a pharmacy level drug alert recall has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for three specific lots of asthma inhalers as they may not deliver the full number doses more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

A Phase I study is set to be initiated by OncoArendi Therapeutics to assess the safety, tolerability and pharmacokinetics of its lead compound and novel drug candidate, OATD-01 for the treatment of asthma. more

News

Digital solution provider for respiratory medicine, Propeller Health, is expanding its digital health collaboration with GlaxoSmithKline (GSK) for the improvement of asthma and chronic obstructive pulmonary disease (COPD) management. more

News

‘Advanced simplicity’ will drive growth for inhalers in emerging markets, Peter Schmelzer, CEO of H&T Presspart tells us more. more

Opinion

A new severe asthma treatment, Reslizumab, has been recommended for use on the NHS by the National Institute for Health and Care Excellence (NICE). more

Technology

The results from the asthma arm of the world’s first digitally enhanced Randomised Controlled Trial (RCT) have been announced. more

News

Positive results from the SLS in asthma have been announced by GSK and Innoviva, demonstrating that patients initiated on treatment with Relvar Ellipta significantly improved asthma control compared with usual care. more

News

The National Institute for Health and Care Excellence has drawn out guidelines recommending the use of pharma company GlaxoSmtihKline’s (GSK) biologic drug for asthma patients on the NHS in England and Wales. more

News

Pharmaceutical companies set to benefit from intelligence on asthma as Aerobit teams with artificial intelligence experts to unlock the potential of big data. more

News

Novartis and the National Institute for Health Research (NIHR) Translational Research Partnership are investigating how omalizumab can be targeted to better treat asthma patients more

News

GlaxoSmithKline’s (GSK) Nucala is the first anti-interleukin-5 (anti-IL-5) treatment for severe asthma approved by the US Food and Drug Administration (FDA) more

News

Mylan has launched the first bioequivalent alternative to GlaxoSmithKline’s Seretide Evohaler (salmeterol xinafoate/fluticasone propionate) under the brand name Sirdupla in the UK. more

News

Aptar Pharma’s Prohaler is a smart DPI that has been developed with the patient in mind. This, says Aptar Pharma, makes it intuitive and simple to use by all asthma and COPD patients more

Technology

A new report finds that the latest trials in asthma treatments herald a shift towards a personal, individual approach to therapy. more

Technology